Chadi Nabhan, Chief Medical Officer and Head of Strategy at Ryght, shareda post on LinkedIn:
“The latest Healthcare Unfiltered EXPRESS is with the inspiring Sara Tolaney of the Dana-Farber Cancer Institute describing the ASCENT-04 trial that she led as the principle investigator.
Dr. Tolaney is the lead author on the NEJM Group paper reporting on the ASCENT-04 results. She sat with me to discuss what led to this study, what did it show, and how its results must be put in context to optimize managing breast cancer.
Streaming everywhere.
Apple.
YouTube.
Please subscribe, share, review, and join the conversation.”